Protein Purification and Aggregation

Protein aggregation is a biological phenomenon caused by the abnormal interaction of destabilized proteins.1 Characterization of protein behavior in solution is critical, as destabilized proteins are susceptible to chemical and physical alterations leading to loss of function. Most importantly, in protein-based drug development, even minimal amounts of aggregates can cause deleterious effects due to potential change in potency of biopharmaceuticals, and adverse immune response in patients. In addition, the increasing number of biosimilars demands stringent regulatory procedures that properly address product quality analysis by biopharmaceutical companies.3 Many factors can influence protein behavior and aggregation, including temperature, oxidation, concentration, pH, ionic strength, additives, detergent, cryoprotectants, freeze-thaw cycles, and storage and handling conditions. This article explores Ultracentrifugation as a complete workflow solution for protein purification and protein aggregation quantification.

Fill in the form below to download now.


    By checking the box below, please communicate whether you would like to receive communication, including promotional material from Beckman Coulter Life Sciences -

    If you have given your consent above, please confirm how you prefer us to contact you :

    Beckman Coulter Life Sciences Privacy Policy Global Privacy Notice - Beckman Coulter (mybeckman.in) and Terms of Use Online Terms of Use - Beckman Coulter (mybeckman.in)
    This is co-hosted by Express Pharma and Beckman Coulter both parties will process your personal information. Each party will be responsible for managing their own use of your personal information.
    By submitting this form, you are confirming you are an adult 18 years or older and you agree to Express Pharma contacting you with marketing-related emailer, messages, or by telephone. You may unsubscribe from receiving such communications from Express Pharma at any time. Express Pharma web sites and communications are subject to our Privacy Notice and Terms of Use.

    Comments (0)
    Add Comment